These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8303670)

  • 21. Determination of soluble fibrin by turbidimetry of its protamine sulphate-induced paracoagulation.
    Wieding JU; Eisinger G; Köstering H
    J Clin Chem Clin Biochem; 1989 Feb; 27(2):57-63. PubMed ID: 2746164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Course of indicators of thrombin activity in the early phase of acute myocardial infarction: effect of fibrinolytic therapy and acute percutaneous coronary angioplasty.
    Dempfle CE; Kaden JJ; Haase KK; Borggrefe M
    Thromb Haemost; 2003 Jul; 90(1):147-54. PubMed ID: 12876638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinogen-fibrin conversion. The mechanism of fibrin-polymer formation in solution.
    Smith GF
    Biochem J; 1980 Jan; 185(1):1-11. PubMed ID: 7378042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonclottable fibrin obtained from partially reduced fibrinogen: characterization and tissue plasminogen activator stimulation.
    Procyk R; Medved L; Engelke KJ; Kudryk B; Blombäck B
    Biochemistry; 1992 Mar; 31(8):2273-8. PubMed ID: 1540582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
    Dempfle CE
    Thromb Haemost; 1999 Aug; 82(2):673-83. PubMed ID: 10605767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of soluble fibrin monomer complexes by adsorption on immobilized fibrinogen.
    Stemberger AW; Hörmann H
    Thromb Haemost; 1978 Jun; 39(3):574-81. PubMed ID: 568324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retention of thrombin by polytetrafluoroethylene: influence on the adsorption of fibrinogen/fibrin.
    Schlosser E; Simler R; Hörmann H
    Biomaterials; 1993 Apr; 14(5):365-70. PubMed ID: 8507780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of cryoprofibrin in fibrinogen-fibrin conversion.
    SHAINOFF JR; PAGE IH
    J Exp Med; 1962 Nov; 116(5):687-707. PubMed ID: 13988371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
    Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
    J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase in fibrinogen and fibrin-related antigen in human serum due to in vitro lysis of fibrin by thrombin.
    Merskey C; Johnson AJ; Lalezari P
    J Clin Invest; 1972 Apr; 51(4):903-11. PubMed ID: 5014617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release.
    Lane DA; Cuddigan B; VanRoss M; Kakkar VV
    Br J Haematol; 1980 Mar; 44(3):483-94. PubMed ID: 6769460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation.
    Blombäck B; Carlsson K; Fatah K; Hessel B; Procyk R
    Thromb Res; 1994 Sep; 75(5):521-38. PubMed ID: 7992253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    J Lab Clin Med; 1995 Mar; 125(3):384-91. PubMed ID: 7897305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The release of small amounts of fibrinopeptide-B (FPB) is of critical importance for the thrombin clotting time.
    Holm B; Kierulf P; Godal HC
    Thromb Res; 1986 May; 42(4):517-26. PubMed ID: 3715815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The enhanced activation of Glu-plasminogen by urokinase in the presence of fibrin or des A fibrin as measured by the release of B beta peptide and FDP.
    Urano T; Takada Y; Takada A
    Thromb Res; 1984 Dec; 36(5):429-35. PubMed ID: 6084324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of soluble fibrin complexes by agarose gel chromatography and protamine sulfate gelation.
    Latallo ZS; Mattler LE; Bang NU; Hansen MS; Chang ML
    Biochim Biophys Acta; 1976 Jan; 420(1):69-80. PubMed ID: 1247582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple rapid method for isolating soluble fibrin complexes from fibrinogen by treatment with thrombin and t-AMCHA.
    Hayashi S; Yamada K
    Thromb Haemost; 1980 Feb; 42(5):1388-97. PubMed ID: 6154323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cleavage sequence of fibrinopeptide A from fibrinogen fragment E by thrombin, atroxin or batroxobin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):107-12. PubMed ID: 8457636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.